Trial intelligence / Profile preview

Hydroxyurea for EBV-Associated PCNSL in AIDS

NCT00002940Phase 2Completed

Sponsor
St. Jude Children's Research Hospital
Start
Oct 1996
Primary completion
Mar 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hydroxyurea in primary central nervous system lymphoma (PCNSL), sponsored by St. Jude Children's Research Hospital. Started Oct 1996; status: completed.

02

Drugs

hydroxyurea
03

Conditions

primary central nervous system lymphoma (PCNSL)

Beyond the preview

Go deeper on NCT00002940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call